Tradestie Institutional Equity Comparison Engine
CON vs GRDN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CON Overall Edge
CON Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Concentra Group Holdings Parent, Inc. (CON) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CON trades at 22.0x Forward P/E with 17.2% operating margin (+8.6% YoY revenue) versus GRDN at 31.3x Forward P/E and 6.5% operating margin (-1.7% YoY). In options structure, CON sits in BREAKOUT (95th %ile IV; Dealer Gamma Walls on Pro) against GRDN sits in SURGE (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CON
CON 22.0x vs GRDN 31.3x Fwd P/E
Growth & Margin Winner
CON
Op Margin 17.2% vs 6.5% ยท YoY +8.6% vs -1.7%
Momentum & Technical Winner
CON
1Y +117.6% vs +70.4% ยท 52W Pos 91% vs 84%
Options & Structure Winner
CON
BREAKOUT (95th %ile IV) vs SURGE (7th %ile IV)
CON
NYSE
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap
$5.2B
1M Return
+4.68%
1Y Return
+117.58%
Forward P/E
22.0x
Unified AI Score
43.5 / 100
HOLD
Tech 31.0
Fund 47.0
Flow 69.0
Mom 41.1
GRDN
NYSE
Guardian Pharmacy Services, Inc.
Retail-Drug Stores And Proprietary Stores
$46.94
+0.58% 1D
Market Cap
$3.0B
1M Return
+18.57%
1Y Return
+70.38%
Forward P/E
31.3x
Unified AI Score
35.9 / 100
SELL
Tech 8.0
Fund 35.0
Flow 56.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CON +117.58%
GRDN +70.38%
Spread: +47.2 pp (CON Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CON Revenue | GRDN Revenue | CON Op. Margin | GRDN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | $1.72B | N/A | 15.0% | N/A | CON |
| FY2023 | $1.84B | N/A | 15.6% | N/A | CON |
| FY2024 | $1.90B | $1.23B | 16.0% | -5.1% | CON |
| FY2025 | $2.16B | $1.45B | 15.4% | 5.0% | CON |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CON | GRDN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $3.0B | Larger Scale | CON |
| Trailing P/E Ratio Valuation | 24.5x | 39.9x | Lower Multiple | CON |
| Forward P/E Ratio Valuation | 22.0x | 31.3x | Lower Multiple | CON |
| Revenue Growth (YoY) Growth | +8.6% | -1.7% | Higher Growth | CON |
| Operating Margin (TTM) Profitability | 17.2% | 6.5% | Higher Margin | CON |
| Net Profit Margin Profitability | 9.3% | 5.1% | Higher Margin | CON |
| Return on Equity (ROE) Capital Efficiency | 47.2% | 32.0% | Higher ROE | CON |
| 52-Week Range Position Momentum | 91% ($19โ$44) | 84% ($26โ$51) | Stronger Trend | CON |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 38% Vol | 0.51ฮฒ ยท 56% Vol | Lower Realized Risk | CON |
| Unified Institutional Score Composite Signal | 43.5 / 100 (HOLD) | 35.9 / 100 (SELL) | Higher Composite | CON |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CON vs GRDN Buy Guide
CON
BREAKOUT
99d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
95th %ile
IV Regime
Extreme (>80th %ile)
GRDN
SURGE
7d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CON nor GRDN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.